Claims for Patent: 9,756,871

Summary for Patent: 9,756,871

Title:	TAL-mediated transfer DNA insertion
Abstract:	The invention relates to methods for stably integrating a desired polynucleotide into a plant genome, comprising transforming plant material with a first vector comprising nucleotide sequences encoding TAL proteins designed to recognize a target sequence; transforming the plant material with a second vector comprising (i) a marker gene that is not operably linked to a promoter (\"promoter-free marker cassette\") and which comprises a sequence homologous to the target sequence; and (ii) a desired polynucleotide; and identifying transformed plant material in which the desired polynucleotide is stably integrated.
Inventor(s):	Rommens; Caius M. (Boise, ID), Duan; Hui (Boise, ID), Weeks; J. Troy (Boise, ID)
Assignee:	J.R. Simplot Company (Boise, ID)
Application Number:	14/084,406
Patent Claims:	1. A transformed potato plant comprising in its genome a sequence exogenous to the untransformed plant, said sequence comprising: (i) a promoter-free marker cassette; and (ii) a desired polynucleotide; wherein the promoter-free marker cassette and the desired polynucleotide are positioned downstream of one of the plant's genomic endogenous Ubi7 gene promoters, and wherein the promoter-free marker cassette is expressed by said genomic endogenous Ubi7 gene promoter. 2. The transformed potato plant of claim 1, wherein the desired polynucleotide comprises a silencing cassette targeting one or more genes selected from the group consisting of asparagine synthase 1 (Asn1), polyphenol oxidase (Ppo), and vacuolar invertase (Inv) genes. 3. The transformed potato plant of claim 2, wherein the desired polynucleotide further expresses a late blight resistance gene Vnt1. 4. The transformed potato plant of claim 3, wherein said transformed potato plant is capable of producing tubers wherein the plant has a phenotype characterized by one or more of black spot bruise tolerance, reduced cold-induced sweetening and reduced asparagine levels in its tubers as a result of the expression of the desired polynucleotide. 5. A heat-processed product, wherein said heat processed product comprises cells from the transformed potato plant of claim 4. 6. The heat-processed product of claim 5, wherein the product is a French fry, chip, crisp, potato, dehydrated potato or baked potato. 7. The heat-processed product of claim 5, wherein the heat-processed product has a lower level of acrylamide than a heat-processed product of an otherwise identical plant lacking the desired polynucleotide. 8. The transformed potato plant of claim 1, wherein the promoter-free marker cassette encodes a mutated acetolactate synthase (ALS) gene, and wherein said mutated ALS gene confers the plant with resistance to at least one ALS inhibitor selected from the group consisting of sulfonylureas, imidazolinones, triazolopyrimidines, pyrimidinyl oxybenzoates, and sulfonylamino carbonyl triazolinones. 9. The transformed potato plant of claim 8, wherein the mutated ALS gene encodes for a peptide selected from the group consisting of SEQ ID Nos: 11 and 13. 10. A heat-processed product, wherein said heat processed product comprises cells from the tuber grown from the transformed potato plant of claim 4. 11. A method for stably integrating a desired polynucleotide downstream of a potato plant's endogenous Ubi7 gene promoter, said method comprising: (A) transforming potato plant material with a first vector comprising nucleotide sequences encoding Transcription Activator-Like Effector Nuclease (TAL) proteins designed to recognize a target sequence, wherein the target sequence is located within an intron of the potato plant's endogenous Ubi7 gene 5'-untranslated region; (B) transforming the potato plant material with a second vector comprising (i) a marker gene that is not operably linked to a promoter, referred to as a promoter-free marker cassette, and which comprises a sequence homologous to the target sequence, and (ii) a desired polynucleotide; and (C) identifying transformed potato plant material in which the desired polynucleotide is stably integrated downstream of the potato plant's endogenous Ubi7 gene promoter. 12. The method of claim 11, wherein the transformed plant material is exposed to conditions that reflect the presence or absence of the marker gene in the transformed plant. 13. The method of claim 12, wherein the marker gene is an herbicide resistance gene and the transformed plant material is exposed to herbicide. 14. The method of claims 13, wherein the herbicide resistance gene is a mutated ALS gene, and wherein said mutated ALS gene confers the potato plant with resistance to at least one ALS inhibitor selected from the group consisting of sulfonylureas, imidazolinones, triazolopyrimidines, pyrimidinyl oxybenzoates, and sulfonylamino carbonyl triazolinones. 15. The method of claim 11, wherein the promoter-free marker cassette is stably integrated into the potato plant's genome. 16. A method for the targeted insertion of exogenous DNA downstream of a potato plant's endogenous Ubi7 gene promoter, said method comprising the steps of (i) transforming isolated potato plant cells with (A) a first binary vector comprising a promoter-less cassette comprising (a) a right border sequence linked to (b) a partial sequence of the endogenous Ubi7 gene's intron 5'-untranslated region; (c) a Ubi7 monomer-encoding sequence fused to a mutated ALS gene; (d) a desired nucleotide sequence, wherein the desired nucleotide sequence is not operably linked to a promoter; and (e) a terminator sequence; and (B) a second binary vector comprising (a) a right border; (b) a forward expression cassette and a reverse expression cassette, wherein each expression cassette comprises a nucleotide sequence encoding a modified TAL operably linked to a strong constitutive promoter, and a terminator sequence; and (c) a sequence encoding isopentenyl transferase (ipt), wherein the modified TAL is designed to bind the endogenous Ubi7 gene's intron 5' untranslated region; and (ii) culturing the transformed potato plant cells under conditions that promote growth of edited potato plants that express the desired nucleotide sequence; wherein no vector backbone DNA is permanently inserted into the edited potato plant's genome. 17. The method of claim 16, wherein the modified TAL comprises (a) a truncated C-terminal activation domain comprising a Fokl endonuclease catalytic domain; (b) a codon-optimized target sequence binding domain comprising 16.5 repeat variable diresidues corresponding to the endogenous Ubi7 5'-untranslated intron sequence; and (c) an N-terminal region comprising a SV40 nuclear localization sequence. 18. The method of claim 16, wherein the desired nucleotide sequence is a silencing cassette targeting one or more genes selected from the group consisting of Asn1, Ppo, and Inv genes. 19. The method of claim 16, wherein the first binary vector further comprises a late blight resistance gene Vnt1 operably linked to its native promoter and terminator sequences.

Details for Patent 9,756,871

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2032-11-20
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2032-11-20
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2032-11-20